Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease

Small series suggest mycophenolate mofetil (MMF) is well tolerated and may be an effective therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD). We examined the tolerability and longitudinal changes in pulmonary physiology in a large and diverse cohort of patients wit...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of rheumatology Vol. 40; no. 5; p. 640
Main Authors:	Fischer, Aryeh, Brown, Kevin K, Du Bois, Roland M, Frankel, Stephen K, Cosgrove, Gregory P, Fernandez-Perez, Evans R, Huie, Tristan J, Krishnamoorthy, Mahalakshmi, Meehan, Richard T, Olson, Amy L, Solomon, Joshua J, Swigris, Jeffrey J
Format:	Journal Article
Language:	English
Published:	Canada 01.05.2013
Subjects:	Connective Tissue Diseases - complications Connective Tissue Diseases - diagnosis Connective Tissue Diseases - drug therapy Connective Tissue Diseases - physiopathology Female Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Longitudinal Studies Lung - drug effects Lung - physiopathology Lung Diseases, Interstitial - diagnosis Lung Diseases, Interstitial - drug therapy Lung Diseases, Interstitial - etiology Lung Diseases, Interstitial - physiopathology Male Middle Aged Mycophenolic Acid - adverse effects Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Patient Dropouts Respiratory Function Tests CONNECTIVE TISSUE DISEASE INTERSTITIAL LUNG DISEASE MYCOPHENOLATE MOFETIL
ISSN:	0315-162X, 1499-2752, 1499-2752
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!